Supplements promising similar results to Ozempic have taken over social media, but the TGA and health experts have concerns.

potential once-monthly injectable GLP-1 RA engineered with Metsera’s HALO™ lipidation platform. MET-097i showed a 7.5% reduction in body weight from baseline at day 36 and a 380-hour half-life.

ATLANTA — Popular drugs like Ozempic and Wegovy are known for dramatic weight loss, but they also can potentially help with ...

A study of Gila monster venom helped start the revolution in weight-loss drugs. But scientists think that’s just the ...

Wave Life Sciences Ltd. (NASDAQ:WVE ... to unlock the next frontier in obesity treatment and address the millions impacted by ...

As diabetes cases surge across Europe, healthcare systems are grappling with an escalation, leaving millions without ...

Good morning, and welcome to the Wave Life Sciences Third Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen only mode. As a reminder, this call is being ...

We plan to submit an IND for the first of these indications by the end of 2024 and preparations are underway for the ...

Stroke survivors who took GLP-1 or SGLT2 medications had a 74% lower risk of death, according to a preliminary study being presented at the American Heart Association's annual Scientific Sessions, set ...

REMAIN-1 weight maintenance pivotal study enrollment progressing rapidly; mid-point data analysis expected in Q2 2025 ...

Becton, Dickinson plans to reduce debt and repurchase $1B in shares. Read why BDX stock is a solid Buy, enhancing financial ...

plus additional ~$28 million net proceeds received on October 1 from full exercise of greenshoe option, with runway expected into 2027 Investor conference call and webcast at 8:30 a.m. ET today ...